SCHEMBL402418

SCHEMBL402418

COC(=O)c1ccc(-c2nc(C)ccc2C(=O)O)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.46
KDM4E B2RXH2 7/20 0.46
ALDH1A1 P00352 7/20 0.46
MAPT P10636 4/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
GAA P10253 2/20 0.46
LMNA P02545 2/20 0.46
HPGD P15428 5/20 0.44
RXFP1 Q9HBX9 1/20 0.44
HSD17B10 Q99714 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
NFKB1 P19838 1/20 0.44
NFKB2 Q00653 1/20 0.44
RELA Q04206 1/20 0.44
ATM Q13315 1/20 0.44
MAPK1 P28482 2/20 0.44
TP53 P04637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL404075 0.81 PKM (0.52) TDP1KDM4EALDH1A1MAPTMEN1
SCHEMBL5532405 0.79 ALDH1A1 (0.54) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL9301820 0.78 SLC6A3 (0.50) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL7566122 0.78 NPC1 (0.61) ALDH1A1MAPTLMNAHPGDHSD17B10
SCHEMBL30079151 0.77 CA1 (0.57) TDP1KDM4EALDH1A1MAPTMEN1
SCHEMBL9355817 0.77 GABRP (0.48) TDP1KDM4EALDH1A1MEN1KMT2A
SCHEMBL10600277 0.76 TSHR (0.53) TDP1KDM4EALDH1A1MAPTMEN1
SCHEMBL29575047 0.76 TDP1 (0.61) TDP1KDM4EALDH1A1MAPTMEN1
SCHEMBL400608 0.75 NTRK1 (0.52) KDM4EALDH1A1HPGDHSD17B10DHODH
SCHEMBL30775057 0.74 NPSR1 (0.47) TDP1KDM4EALDH1A1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8101774-B2 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2012-01-24 US disclosed
US-8101774-B2 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2012-01-24 US disclosed
US-8101774-B2 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2012-01-24 US disclosed
CN-101056628-B Ester derivatives and medicinal use thereof JAPAN TOBACCO INC 2011-05-25 CN disclosed
CN-101056628-A Ester derivatives and medicinal use thereof JAPAN TOBACCO INC (JP) 2007-10-17 CN disclosed
EP-1803452-A1 ESTER DERIVATIVE AND PHARMACEUTICAL USE THEREOF Japan Tobacco, Inc. (JP) 2007-07-04 EP disclosed
US-20060089392-A1 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060089392-A1 Ester derivatives and medicinal use thereof MTTP, CETP, LIPA TDP1 582/4885KDM4E 2908/4885ALDH1A1 421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.